Vernazza PL - Search Results

1

Higher CNS penetration-effectiveness of long-term combination antiretroviral therapy is associated with better HIV-1 viral suppression in cerebrospinal fluid.

Cusini A, Vernazza PL, Yerly S, Decosterd LA, Ledergerber B, Fux CA, Rohrbach J, Widmer N, Hirschel B, Gaudenz R, Cavassini M, Klimkait T, Zenger F, Gutmann C, Opravil M, Günthard HF; Swiss HIV Cohort Study. Cusini A, et al. Among authors: vernazza pl. J Acquir Immune Defic Syndr. 2013 Jan 1;62(1):28-35. doi: 10.1097/QAI.0b013e318274e2b0. J Acquir Immune Defic Syndr. 2013. PMID: 23018371

2

A controlled study of inhaled pentamidine for primary prevention of Pneumocystis carinii pneumonia.

Hirschel B, Lazzarin A, Chopard P, Opravil M, Furrer HJ, Rüttimann S, Vernazza P, Chave JP, Ancarani F, Gabriel V, et al. Hirschel B, et al. N Engl J Med. 1991 Apr 18;324(16):1079-83. doi: 10.1056/NEJM199104183241602. N Engl J Med. 1991. PMID: 2008181 Free article. Clinical Trial.

3

Primary prevention of Pneumocystis carinii pneumonia by inhalation of pentamidine. Preliminary results from a placebo-controlled randomized trial. Swiss Group for Clinical Studies on AIDS.

Hirschel B, Chopard P, Chave JP, Furrer HJ, Opravil M, Hilti P, Vernazza P, Lazzarin A. Hirschel B, et al. Med Klin (Munich). 1990 Apr;85 Suppl 2:268-70. Med Klin (Munich). 1990. PMID: 2197536 Clinical Trial.

4

[Prevalence of transmission of zidovudine-resistant viruses in Switzerland. l'Etude suisse de cohorte VIH].

Yerly S, Rakik A, Kinloch-de-Loes S, Erb P, Vernazza P, Hirschel B, Perrin L. Yerly S, et al. Schweiz Med Wochenschr. 1996 Oct 26;126(43):1845-8. Schweiz Med Wochenschr. 1996. PMID: 9005525 French.

5

Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study. Swiss HIV Cohort Study.

Egger M, Hirschel B, Francioli P, Sudre P, Wirz M, Flepp M, Rickenbach M, Malinverni R, Vernazza P, Battegay M. Egger M, et al. BMJ. 1997 Nov 8;315(7117):1194-9. doi: 10.1136/bmj.315.7117.1194. BMJ. 1997. PMID: 9393221 Free PMC article. Clinical Trial.

6

A placebo-controlled trial of didanosine plus stavudine, with and without hydroxyurea, for HIV infection. The Swiss HIV Cohort Study.

Rutschmann OT, Opravil M, Iten A, Malinverni R, Vernazza PL, Bucher HC, Bernasconi E, Sudre P, Leduc D, Yerly S, Perrin LH, Hirschel B. Rutschmann OT, et al. Among authors: vernazza pl. AIDS. 1998 May 28;12(8):F71-7. doi: 10.1097/00002030-199808000-00003. AIDS. 1998. PMID: 9631134 Clinical Trial.

7

Highly active antiretroviral therapy during early HIV infection reverses T-cell activation and maturation abnormalities. Swiss HIV Cohort Study.

Bisset LR, Cone RW, Huber W, Battegay M, Vernazza PL, Weber R, Grob PJ, Opravil M. Bisset LR, et al. Among authors: vernazza pl. AIDS. 1998 Nov 12;12(16):2115-23. doi: 10.1097/00002030-199816000-00006. AIDS. 1998. PMID: 9833852

8

Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study. Swiss HIV Cohort Study.

Ledergerber B, Egger M, Opravil M, Telenti A, Hirschel B, Battegay M, Vernazza P, Sudre P, Flepp M, Furrer H, Francioli P, Weber R. Ledergerber B, et al. Lancet. 1999 Mar 13;353(9156):863-8. doi: 10.1016/s0140-6736(99)01122-8. Lancet. 1999. PMID: 10093977

9

Discontinuation of primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1-infected adults treated with combination antiretroviral therapy. Swiss HIV Cohort Study.

Furrer H, Egger M, Opravil M, Bernasconi E, Hirschel B, Battegay M, Telenti A, Vernazza PL, Rickenbach M, Flepp M, Malinverni R. Furrer H, et al. Among authors: vernazza pl. N Engl J Med. 1999 Apr 29;340(17):1301-6. doi: 10.1056/NEJM199904293401701. N Engl J Med. 1999. PMID: 10219064 Free article. Clinical Trial.

10

Why is highly active antiretroviral therapy (HAART) not prescribed or discontinued? Swiss HIV Cohort Study.

Bassetti S, Battegay M, Furrer H, Rickenbach M, Flepp M, Kaiser L, Telenti A, Vernazza PL, Bernasconi E, Sudre P. Bassetti S, et al. Among authors: vernazza pl. J Acquir Immune Defic Syndr. 1999 Jun 1;21(2):114-9. J Acquir Immune Defic Syndr. 1999. PMID: 10360802

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

404 results

Search Page

Filters